Who owns Liminatus Pharma Inc A?
- Ticker: LIMN
- CUSIP Number: 53271x108
Tip: Access positions for across all investors
Analyze quarterly positions in Liminatus Pharma Inc A with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Liminatus Pharma Inc A stock
Who bought or sold Liminatus Pharma Inc A this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 73k | $45k | 0% | Dec 2025 |
|
| Citadel Advisors | 71k | $43k | 100% | Dec 2025 |
|
| Geode Capital Management | 65k | $40k | 2% | Dec 2025 |
|
| Two Sigma Investments | 35k | $22k | 100% | Dec 2025 |
|
| UBS Group | 19k | $12k | -52% | Dec 2025 |
|
| State Street Corporation | 19k | $12k | 0% | Dec 2025 |
|
| BlackRock | 13k | $8.1k | 0% | Dec 2025 |
|
| Two Sigma Securities | 12k | $7.2k | 100% | Dec 2025 |
|
| Tower Research Capital | 8.9k | $5.4k | 382% | Dec 2025 |
|
| Farther Finance Advisors | 14.00 | $2.000600 | -55% | Mar 2026 |
|
Who sold out of Liminatus Pharma Inc A?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Sep 2025 | 40k | $66k |
| Squarepoint Ops | Sep 2025 | 10k | $17k |